Tubal Disease and Hydrosalpinx: Management and Ectopic Pregnancy Vigilance

This is usually a fungal infection, and both partners need treatment, along with lactobacillus supplements. Because a wet mount or culture can miss organisms such as Trichomonas, Chlamydia or Mycoplasma, Dr. Pai often gives combination therapy (an antifungal such as fluconazole plus an antibiotic such as azithromycin) with local clotrimazole cream, and screens for diabetes, since fungal infections are common in patients who are obese or diabetic.

If antibody titres are very high, management becomes difficult. Where it is legally available, Dr. Pai suggested surrogacy carried by an Rh-negative surrogate as a way to avoid maternal antibody-mediated complications and repeated interventions such as cord blood transfusion, rather than risking complications like kernicterus in the baby.

Not universally. Dr. Pai calls clomiphene his master drug and reserves letrozole specifically for PCOS patients. His practice stratifies by AMH and antral follicle count: normal responders (AMH 2 to 3.5 ng/ml, AFC 7 to 15) receive clomiphene or clomiphene plus HMG; poor responders (AMH under 1.5, AFC under 7) also receive clomiphene plus HMG; hyper-responders with PCOS (AMH over 3.5, AFC over 15) receive letrozole; pure HMG is reserved for IVF cycles.

Answered by the Jivo Healthcare coordination team rather than Dr. Pai directly: each referring doctor is assigned a relationship manager who collects and documents the case file, shares it with the Fortis coordinator and Dr. Pai's team, and returns a review with further guidance within 48 to 72 hours.

Three drug classes now exist: GLP-1 agonists (semaglutide), GLP-1/GIP combinations (tirzepatide, marketed as Mounjaro), and a GLP-1/GIP/glucagon combination about to be released. Injectable semaglutide starts at 0.25 mg subcutaneously, rising gradually to 2.4 mg; an oral form (Rybelsus) is also available but must be taken daily rather than weekly. Mounjaro, launched in the US two years earlier at roughly $1,000 a month, was released in India at about one-sixth of that cost (roughly Rs 15,000 to 20,000 a month) because of the scale of global obesity; with semaglutide's patent expiring in March and around eleven companies preparing to launch competing versions in India by April, prices are expected to fall further.

Severe hydrosalpinx is removed or disconnected from the uterus before proceeding to IVF rather than attempting IUI, since the fluid buildup in a diseased tube reduces the odds of a successful pregnancy.

His sequencing often reverses the usual order: he retrieves eggs and freezes the resulting embryos first, then removes the hydrosalpinx by laparoscopy afterward, because operating after retrieval avoids putting the stimulation cycle at risk.

Freeing the tube in that situation risks bowel injury, so the tube is instead disconnected from the uterus proximally rather than removed entirely.

Mild tubal disease can be managed with IUI, but only with caution, since any tubal pathology carries an elevated risk of ectopic pregnancy.

Patients who miss a period are asked to come in immediately for a beta-hCG blood test, repeated every 48 hours. A normal intrauterine pregnancy shows a rise of at least 60 percent over that interval; a slower rise raises suspicion of an ectopic, and if beta-hCG is positive with no visible pregnancy in the uterine cavity by 6 to 7 weeks, methotrexate may be given empirically rather than surgery.